인쇄하기
취소

KSE-Listed Firms Show Strong Financial Results for Three Quarters

Published: 2005-02-21 06:59:00
Updated: 2005-02-21 06:59:00

The 3rd quarter year-to-date (YTD) financial results for KSE-listed pharmaceutical firms, with their fiscal year ending March 2005, collectively show over 12 percent growth in revenue, propelled by aggressive marketing promotions on the leading products in the market.

According to an analysis conducted by the Yakup Shinmoon, the total revenue for these firms through three quarters is 7...


Fees

- Email service daily and homepage access.
  1. $300 per month.
  2. 5 Email holders per each company.
  3. Anual contract base.
Copyright Yakup.com All rights reserved.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.